|
1
|
Moding EJ, Kastan MB and Kirsch DG:
Strategies for optimizing the response of cancer and normal tissues
to radiation. Nat Rev Drug Discov. 12:526–542. 2013.
|
|
2
|
Löfdahl E, Berg G, Johansson KA, et al:
Compromised quality of life in adult patients who have received a
radiation dose towards the basal part of the brain. A case-control
study in long-term survivors from cancer in the head and neck
region. Radiat Oncol. 7:1792012.
|
|
3
|
Raabe A, Derda K, Reuther S, et al:
Association of single nucleotide polymorphisms in the genes ATM,
GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema
after breast conserving radiotherapy. Radiat Oncol. 7:652012.
|
|
4
|
Mangoni M, Vozenin MC, Biti G and Deutsch
E: Normal tissues toxicities triggered by combined anti-angiogenic
and radiation therapies: hurdles might be ahead. Br J Cancer.
107:308–314. 2012.
|
|
5
|
Nieder C, Jeremic B, Astner S and Molls M:
Radiotherapy-induced lung toxicity: risk factors and prevention
strategies. Anticancer Res. 23:4991–4998. 2003.
|
|
6
|
Nieder C, Andratschke N and Astner ST:
Experimental concepts for toxicity prevention and tissue
restoration after central nervous system irradiation. Radiat Oncol.
2:232007.
|
|
7
|
Nieder C, Astner ST, Grosu AL and Molls M:
Evaluation of late neurologic adverse events in patients with brain
metastases from non-small cell lung cancer. Anticancer Res.
27:1701–1704
|
|
8
|
Young NS, Ioannidis JPA and Al-Ubaydli O:
Why current publication practices may distort science. PLoS Med.
5:e2012008.
|
|
9
|
Kanaan Z, Galandiuk S, Abby M, et al: The
value of lesser-impact-factor surgical journals as a source of
negative and inconclusive outcomes reporting. Ann Surg.
253:619–623. 2011.
|
|
10
|
Durieux V and Gevenois PA: Bibliometric
indicators: quality measurements of scientific publication.
Radiology. 255:342–351. 2010.
|
|
11
|
Radicchi F, Fortunato S and Castellano C:
Universality of citation distributions: toward an objective measure
of scientific impact. Proc Natl Acad Sci USA. 105:17268–17272.
2008.
|
|
12
|
Vinkler P: Relations of relative
scientometric indicators. Scientometrics. 58:687–694. 2003.
|
|
13
|
Nieder C, Astner ST and Grosu AL:
Glioblastoma research 2006–2010: pattern of citation and systematic
review of highly cited articles. Clin Neurol Neurosurg.
114:1207–1210. 2012.
|
|
14
|
Bentzen SM: Preventing or reducing late
side effects of radiation therapy: Radiobiology meets molecular
pathology. Nat Rev Cancer. 6:702–713. 2006.
|
|
15
|
François S, Bensidhoum M, Mouiseddine M,
et al: Local irradiation not only induces homing of human
mesenchymal stem cells at exposed sites but promotes their
widespread engraftment to multiple organs: A study of their
quantitative distribution after irradiation damage. Stem Cells.
24:1020–1029. 2006.
|
|
16
|
Kong FM, Hayman JA, Griffith KA, et al:
Final toxicity results of a radiation-dose escalation study in
patients with non-small-cell lung cancer (NSCLC): predictors for
radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys.
65:1075–1086. 2006.
|
|
17
|
Wazer DE, Kaufman S, Cuttino L, DiPetrillo
T and Arthur DW: Accelerated partial breast irradiation: an
analysis of variables associated with late toxicity and long-term
cosmetic outcome after high-dose-rate interstitial brachytherapy.
Int J Radiat Oncol Biol Phys. 64:489–495. 2006.
|
|
18
|
Braam PM, Terhaard CH, Roesink JM and
Raaijmakers CP: Intensity-modulated radiotherapy significantly
reduces xerostomia compared with conventional radiotherapy. Int J
Radiat Oncol Biol Phys. 66:975–980. 2006.
|
|
19
|
Bentzen SM and Trotti A: Evaluation of
early and late toxicities in chemoradiation trials. J Clin Oncol.
25:4096–4103. 2007.
|
|
20
|
Kouvaris JR, Kouloulias VE and Vlahos LJ:
Amifostine: the first selective-target and broad-spectrum
radioprotector. Oncologist. 12:738–747. 2007.
|
|
21
|
Söhn M, Yan D, Liang J, et al: Incidence
of late rectal bleeding in high-dose conformal radiotherapy of
prostate cancer using equivalent uniform dose-based and
dose-volume-based normal tissue complication probability models.
Int J Radiat Oncol Biol Phys. 67:1066–1073. 2007.
|
|
22
|
Shirazi A, Ghobadi G and Ghazi-Khansari M:
A radiobiological review on melatonin: a novel radioprotector. J
Radiat Res. 48:263–272. 2007.
|
|
23
|
Giotopoulos G, Symonds RP, Foweraker K, et
al: The late radiotherapy normal tissue injury phenotypes of
telangiectasia, fibrosis and atrophy in breast cancer patients have
distinct genotype-dependent causes. Br J Cancer. 96:1001–1007.
2007.
|
|
24
|
Kirkpatrick JP, Meyer JJ and Marks LB: The
linear-quadratic model is inappropriate to model high dose per
fraction effects in radiosurgery. Semin Radiat Oncol. 18:240–243.
2008.
|
|
25
|
Fiorino C, Fellin G, Rancati T, et al:
Clinical and dosimetric predictors of late rectal syndrome after
3D-CRT for localized prostate cancer: preliminary results of a
multicenter prospective study. Int J Radiat Oncol Biol Phys.
70:1130–1137. 2008.
|
|
26
|
Mayer R and Sminia P: Reirradiation
tolerance of the human brain. Int J Radiat Oncol Biol Phys.
70:1350–1360. 2008.
|
|
27
|
Clarke RE, Tenorio LM, Hussey JR, et al:
Hyperbaric oxygen treatment of chronic refractory radiation
proctitis: a randomized and controlled double-blind crossover trial
with long-term follow-up. Int J Radiat Oncol Biol Phys. 72:134–143.
2008.
|
|
28
|
Burri RJ, Stock RG, Cesaretti JA, et al:
Association of single nucleotide polymorphisms in SOD2, XRCC1 and
XRCC3 with susceptibility for the development of adverse effects
resulting from radiotherapy for prostate cancer. Radiat Res.
170:49–59. 2008.
|
|
29
|
Fiorino C, Valdagni R, Rancati T and
Sanguineti G: Dose-volume effects for normal tissues in external
radiotherapy: pelvis. Radiother Oncol. 93:153–167. 2009.
|
|
30
|
Barnett GC, West CM, Dunning AM, et al:
Normal tissue reactions to radiotherapy: towards tailoring
treatment dose by genotype. Nat Rev Cancer. 9:134–142. 2009.
|
|
31
|
Weiss JF and Landauer MR: History and
development of radiation-protective agents. Int J Radiat Biol.
85:539–573. 2009.
|
|
32
|
Zhao W and Robbins ME: Inflammation and
chronic oxidative stress in radiation-induced late normal tissue
injury: therapeutic implications. Curr Med Chem. 16:130–143.
2009.
|
|
33
|
Yuan X, Liao Z, Liu Z, et al: Single
nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is
associated with the risk of radiation pneumonitis in patients with
non-small-cell lung cancer treated with definitive radiotherapy. J
Clin Oncol. 27:3370–3378. 2009.
|
|
34
|
Michalski JM, Gay H, Jackson A, et al:
Radiation dose-volume effects in radiation-induced rectal injury.
Int J Radiat Oncol Biol Phys. 76(Suppl 3): S123–S129. 2010.
|
|
35
|
Bentzen SM, Constine LS, Deasy JO, et al:
Quantitative Analyses of Normal Tissue Effects in the Clinic
(QUANTEC): an introduction to the scientific issues. Int J Radiat
Oncol Biol Phys. 76(Suppl 3): S3–S9. 2010.
|
|
36
|
Citrin D, Cotrim AP, Hyodo F, et al:
Radioprotectors and mitigators of radiation-induced normal tissue
injury. Oncologist. 15:360–371. 2010.
|
|
37
|
Yarnold J and Brotons MC: Pathogenetic
mechanisms in radiation fibrosis. Radiother Oncol. 97:149–161.
2010.
|
|
38
|
Gulliford SL, Foo K, Morgan RC, et al:
Dose-volume constraints to reduce rectal side effects from prostate
radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397. Int J
Radiat Oncol Biol Phys. 76:747–754. 2010.
|
|
39
|
Nieder C: Highly cited German research
contributions to the fields of radiation oncology, biology, and
physics: focus on collaboration and diversity. Strahlenther Onkol.
188:865–872. 2012.
|
|
40
|
Kondziolka D: Citation measures in
stereotactic radiosurgery: publication across a discipline.
Stereotact Funct Neurosurg. 89:56–61. 2011.
|
|
41
|
Stringer MJ, Sales-Pardo M and Nunes
Amaral LA: Statistical validation of a global model for the
distribution of the ultimate number of citations accrued by papers
published in a scientific journal. J Am Soc Inf Sci Technol.
61:1377–1385. 2010.
|
|
42
|
Kulkarni AV, Aziz B, Shams I and Busse JW:
Author self-citation in the general medicine literature. PLoS One.
6:e208852011.
|
|
43
|
Maraldo MV, Brodin NP, Aznar MC, et al:
Estimated risk of cardiovascular disease and secondary cancers with
modern highly conformal radiotherapy for early-stage mediastinal
Hodgkin lymphoma. Ann Oncol. 24:2113–2118. 2013.
|
|
44
|
Darby SC, Ewertz M, McGale P, et al: Risk
of ischemic heart disease in women after radiotherapy for breast
cancer. N Engl J Med. 368:987–998. 2013.
|
|
45
|
Padovani L, André N, Constine LS and
Muracciole X: Neurocognitive function after radiotherapy for
paediatric brain tumours. Nat Rev Neurol. 8:578–588. 2012.
|
